Sort
11,323 grants matching “glioblastoma”
Identifying New Glioma-Associated Tumor Suppressors and Oncogenes
$516,832Mark Gilbert · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Translational Immunology
$516,832Mark Gilbert · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Rare Central Nervous System Cancers Initiative
$516,832Mark Gilbert · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Fluorinated macrocyclic peptides as BBB penetrating agent for improved GBM treatment
$516,442Sean Edward Lawler · Brown University · R01 · FY2022 · CA
Targeting Ferritin in Glioblastoma
$516,320Jeremy N Rich · Cleveland Clinic Lerner Com-Cwru · R01 · FY2014 · CA
Uncovering exRNA and protein determinants of secreted vesicle heterogeneity by flow cytometric purification of vesicle subsets from cells and plasma
$516,236Robert J Coffey · Vanderbilt University Medical Center · UG3 · FY2020 · CA
IDO1 and Immunotolerance in Glioblastoma
$515,890Derek Alan Wainwright · Loyola University Chicago · R01 · FY2023 · NS
Radiogenomics Framework for Non-Invasive Personalized Medicine
$515,525Olivier Gevaert · Stanford University · R01 · FY2015 · EB
Defining cellular states of quiescence in human brain tumors
$515,443Patrick Paddison · Fred Hutchinson Cancer Center · R01 · FY2025 · NS
Defining cellular states of quiescence in human brain tumors
$515,443Patrick Paddison · Fred Hutchinson Cancer Center · R01 · FY2023 · NS
The role of collagen and its signaling mechanisms in glioma progression and invasion.
$515,373Pedro R Lowenstein · University Of Michigan At Ann Arbor · R01 · FY2023 · NS
Radioiodinated Multifunctional PARP1 Imaging Probes for Diagnosis and Therapy
$515,195Thomas Reiner · Sloan-Kettering Inst Can Research · R01 · FY2019 · CA
Hydrogen sulfide functions as a tumor suppressor in glioblastoma
$515,147Christopher Michael Hine · Cleveland Clinic Lerner Com-Cwru · R01 · FY2023 · NS
Hydrogen sulfide functions as a tumor suppressor in glioblastoma
$515,147Christopher Michael Hine · Cleveland Clinic Lerner Com-Cwru · R01 · FY2025 · NS
Methylation and mutations in RB1 and variants of synthetic folic acid metabolism
$515,071Manuela A Orjuela · Columbia University Health Sciences · R01 · FY2016 · CA
PHOSPHATDYLINOSITOL-3-P AND GROWTH REGULATION
$514,944Lewis C Cantley · Beth Israel Deaconess Medical Center · R01 · FY2009 · GM
Fatty Acid Metabolic Regulation of Anti-Tumor Immunity Against Irradiated Glioblastoma
$514,923Claire Isabelle Vanpouille-Box · Weill Medical Coll Of Cornell Univ · R01 · FY2024 · NS
Manipulating normal estrogen physiology as a therapeutic approach in cancer
$514,902Donald P McDonnell · Duke University · R01 · FY2024 · CA
Physical Limits of Quantitative SPECT
$514,749Marie Foley Kijewski · Brigham And Women'S Hospital · R01 · FY2006 · EB
Brain tumors with regulatory T-cells treated with EGFRvIII-specific T-cells
$514,429John H Sampson · Duke University · R01 · FY2015 · CA
Project 1: Blood Immunomethylomic Markers of Outcome in Glioblastoma Patients
$514,271John K. Wiencke · University Of California, San Francisco · P50 · FY2022 · CA
Project 1: Blood Immunomethylomic Markers of Outcome in Glioblastoma Patients
$514,270John K. Wiencke · University Of California, San Francisco · P50 · FY2021 · CA
Improving Image-Guided Radiation Therapy of Gliomas with High-Resolution MR Spectroscopic Imaging
$514,161Chao Ma · Massachusetts General Hospital · R01 · FY2022 · EB
A Wireless, Implantable Microdevice for Closed-Loop Drug Delivery to Prevent the Morbidity of Diabetes Therapy-Induced Hypoglycemia
$513,746Amin Arbabian · Stanford University · R01 · FY2021 · EB
Next Gen Virotherapy for GBM
$513,678Balveen Kaur · Augusta University · R01 · FY2024 · NS